Clinuvel Pharma (CLVLF) Stock Price, News & Analysis
Company Description
Clinuvel Pharma (OTC Link: CLVLF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $320.0M.
CLVLF has declined 20.4% over the past year. Shares last traded at $6.37.
This page collects what Stock Titan holds for CLVLF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clinuvel Pharma (CLVLF) stock last closed at $6.37. Over the past 12 months, the stock has lost 20.4%. At a market capitalization of $320.0M, CLVLF is classified as a small-cap stock with approximately 50.4M shares outstanding.
Latest News
SEC Filings
Clinuvel Pharma has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on July 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLVLF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Clinuvel Pharma (CLVLF) currently stands at 2.4 million shares, down 0.5% from the previous reporting period, representing 5.8% of the float. Since July 2025, short interest has increased by 65.3%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Clinuvel Pharma (CLVLF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
CLVLF Company Profile & Sector Positioning
Clinuvel Pharma (CLVLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.